Patents by Inventor Martin Neitzel

Martin Neitzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-cyclic sulfonamido inhibitors of gamma secretase
    Publication number: 20060035884
    Abstract: The invention provides N-cyclic sulfonamido compounds for use in treating or preventing cognitive disorders, such as Alzheimer's Disease. Compounds of particular interest are defined by Formula I, wherein R4, R5, R6, R7, and R8, are as described in the specification. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I as well as methods of treating cognitive disorders, including Alzheimer's disease using compounds of Formula I.
    Type: Application
    Filed: May 20, 2005
    Publication date: February 16, 2006
    Applicant: Elan Pharmaceuticals, Inc.
    Inventors: Martin Neitzel, Jennifer Marugg
  • N-substituted benzene sulfonamides
    Publication number: 20050245573
    Abstract: The invention provides N-substituted benzenesulfonamides for use in treating or preventing cognitive disorders, such as Alzheimer's Disease. Compounds of particular interest are defined by Formula (I), wherein R1, R2, R3, R4, and R3?, are as described in the specification. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders, including Alzheimer's disease using compounds of Formula (I).
    Type: Application
    Filed: March 11, 2005
    Publication date: November 3, 2005
    Inventors: Martin Neitzel, Jennifer Marugg
  • N-substituted benzene sulfonamides
    Publication number: 20050165003
    Abstract: Disclosed are N-substituted benzenesulfonamides for use in treating or preventing cognitive disorders, such as Alzheimer's Disease. In Formula (I), R1, R2, R3, R4, R3?, R10 and R11 are as described herein. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders using compounds of Formula (I).
    Type: Application
    Filed: October 29, 2004
    Publication date: July 28, 2005
    Inventors: Martin Neitzel, Michael Dappen, Jennifer Marugg
  • Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
    Publication number: 20050038099
    Abstract: Disclosed are compounds that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.
    Type: Application
    Filed: April 30, 2004
    Publication date: February 17, 2005
    Inventors: Jay Tung, Albert Garofalo, Michael Pleiss, Jing Wu, David Wone, Ashley Guinn, Darren Dressen, Jennifer Marugg, Martin Neitzel
  • Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
    Publication number: 20050032868
    Abstract: Disclosed are compounds that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.
    Type: Application
    Filed: April 30, 2004
    Publication date: February 10, 2005
    Inventors: Albert Garofalo, Jay Tung, Michael Pleiss, Jing Wu, David Wone, Ashley Guinn, Darren Dressen, Jennifer Marugg, Martin Neitzel
  • Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
    Publication number: 20050020659
    Abstract: Disclosed are compounds that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.
    Type: Application
    Filed: April 30, 2004
    Publication date: January 27, 2005
    Inventors: Jay Tung, Albert Garofalo, Michael Pleiss, Jing Wu, David Wone, Ashley Guinn, Darren Dressen, R. Neitz, Jennifer Marugg, Martin Neitzel
  • Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
    Publication number: 20040147520
    Abstract: Disclosed are sulfonylquinoxalone acetamide derivatives useful as bradykinin antagonists.
    Type: Application
    Filed: May 2, 2003
    Publication date: July 29, 2004
    Inventors: Francine S. Grant, Sarah Bartulis, Louis Brogley, Michael S. Dappen, Ramesh Kasar, Mohammed A. Khan, Martin Neitzel, Michael A. Pleiss, Eugene D. Thorsett, John Tucker, Michael Ye, Jon E. Hawkinson